← All investors
Rapha Capital Management
About
Rapha Capital Management is a Miami investment firm founded in 2017 by oncologic surgeon Kevin Slawin that backs early-stage biotechnology companies. Its BioVentures fund targets Series A leads in oncology, T-cell and immunotherapy, with portfolio companies including Poseida Therapeutics and NexImmune.
Stage focus
Pre-SeedSeedSeries ASeries B
Raising from Rapha Capital Management?
I've worked with founders across the industrial stack. If Rapha Capital Management is on your list, I can help you map the introduction path, sharpen the narrative, and run a tight process.
Talk to Dan